A National Framework for AI Procurement
Summary
As artificial intelligence (AI) applications for public use have proliferated, there has been a large uptick in challenges associated with AI safety and fairness. These challenges are due in part to poor transparency in and standardization of AI procurement protocols, particularly for public-use applications. In this memo, we propose a federal framework—orchestrated through the Office of Federal Procurement Policy (OFPP) situated in the Office of Management and Budget (OMB)—to standardize and guide AI procurement in a safer, fairer manner. While this framework is designed for federal implementation, it is important to recognize that many decisions on AI usage are made by municipalities. The principles guiding the federal framework outlined herein are intended to also help guide development and implementation of similar frameworks for AI procurement at the local level.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.
The Federation of American Scientists supports the National Security Commission on Emerging Biotechnology’s Final Report and the Recommendations contained within it.
The U.S. should create a new non-governmental Innovation Accelerator modeled after the successful In-Q-Tel program to invest in small and mid-cap companies creating technologies that address critical needs of the United States.